85 related articles for article (PubMed ID: 3434146)
1. [Effect of MCNU on growth kinetics of human plasma cell lines--in comparison with melphalan].
Ohnaka T; Ohno T; Kanoh T; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1987 Aug; 50(5):971-7. PubMed ID: 3434146
[No Abstract] [Full Text] [Related]
2. Effect of the nitrosourea anti-tumor chemotherapeutical agent MCNU on five human myeloma cell lines.
Otsuki T; Sakaguchi H; Yamada O; Yawata Y; Ueki A
Oncol Rep; 1998; 5(4):827-32. PubMed ID: 9625826
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of 2-chlorodeoxyadenosine and melphalan myeloma cell lines.
Hjertner O; Börset M; Waage A
Leuk Res; 1996 Feb; 20(2):155-60. PubMed ID: 8628014
[TBL] [Abstract][Full Text] [Related]
4. The mechanisms of action of antitumor compounds.
Belousova AK
Natl Cancer Inst Monogr; 1977 Mar; (45):183-93. PubMed ID: 73135
[No Abstract] [Full Text] [Related]
5. [In vitro effect of combined use of BH-AC and nitrosourea derivatives against adriamycin-resistant human leukemia cell line].
Oguro M; Sakai C; Takagi T; Matsuura Y
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2403-8. PubMed ID: 1952959
[TBL] [Abstract][Full Text] [Related]
6. Interaction of melphalan and dexamethasone in a human myeloma cell line.
Fernberg JO; Lewensohn R; Skog S
Anticancer Drugs; 1991 Dec; 2(6):565-70. PubMed ID: 1806033
[TBL] [Abstract][Full Text] [Related]
7. Effects of various antineoplastic agents on an established human melanoma cell line (G-361).
García Reverte JM; Bernabeu Esclapez A; Muñoz Ramos J; Vicente Ortega V; Canteras Jordana M
Histol Histopathol; 1995 Jan; 10(1):79-84. PubMed ID: 7756747
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of three nitrosourea derivatives on mammalian cell cycle progression.
Tobey RA; Crissman HA
Cancer Res; 1975 Feb; 35(2):460-70. PubMed ID: 1167349
[TBL] [Abstract][Full Text] [Related]
9. Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cells.
Raje N; Kumar S; Hideshima T; Ishitsuka K; Yasui H; Chhetri S; Vallet S; Vonescu E; Shiraishi N; Kiziltepe T; Elford HL; Munshi NC; Anderson KC
Br J Haematol; 2006 Oct; 135(1):52-61. PubMed ID: 16925573
[TBL] [Abstract][Full Text] [Related]
10. [Action mechanism of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in leukemic cells].
Nakamura T; Hashimoto E; Sasada M; Tsutani H; Kagawa D; Ueda T; Uchida M; Domae N; Ando S; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1985 May; 48(3):734-41. PubMed ID: 3862320
[No Abstract] [Full Text] [Related]
11. Sensitivity of proliferating cultured murine pancreatic tumor cells to selected antitumor agents.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1986 Nov; 77(5):1163-9. PubMed ID: 3464801
[TBL] [Abstract][Full Text] [Related]
12. Effect of a new bifunctional nitrosoureido derivative on human colorectal tumor xenografts.
Kopper L; Lapis K; Csányi E; Horváth T
Anticancer Res; 1981; 1(4):229-33. PubMed ID: 7345967
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor spectra of ranimustine against various human tumors].
Fujimoto S; Tokita H; Nitta K
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2417-22. PubMed ID: 1952961
[TBL] [Abstract][Full Text] [Related]
14. Ectopic cyclin D1 overexpression increases chemosensitivity but not cell proliferation in multiple myeloma.
Kuroda Y; Sakai A; Tsuyama N; Katayama Y; Munemasa S; Asaoku H; Okikawa Y; Nakaju N; Mizuno M; Ogawa K; Nishisaka T; Matsui H; Tanaka H; Kimura A
Int J Oncol; 2008 Dec; 33(6):1201-13. PubMed ID: 19020753
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle phase specificity of antitumor agents.
Bhuyan BK; Scheidt LG; Fraser TJ
Cancer Res; 1972 Feb; 32(2):398-407. PubMed ID: 4258018
[No Abstract] [Full Text] [Related]
16. [DNA damage and anticancer effect].
Kanamaru R; Ishioka C; Konishi Y; Ishikawa S; Shibata H; Wakui A
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):517-23. PubMed ID: 2181939
[TBL] [Abstract][Full Text] [Related]
17. Direct determination of the influence of the cell cycle on the survival of tumor cells exposed to cytotoxic antibodies.
Leibson PJ; Loken MR; Shapiro SJ; Schreiber H
Cancer Res; 1980 Jan; 40(1):56-60. PubMed ID: 7349903
[No Abstract] [Full Text] [Related]
18. The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells.
Maiso P; Ocio EM; Garayoa M; Montero JC; Hofmann F; García-Echeverría C; Zimmermann J; Pandiella A; San Miguel JF
Br J Haematol; 2008 May; 141(4):470-82. PubMed ID: 18341634
[TBL] [Abstract][Full Text] [Related]
19. Interpreting cell cycle effects of drugs: the case of melphalan.
Lupi M; Cappella P; Matera G; Natoli C; Ubezio P
Cancer Chemother Pharmacol; 2006 Apr; 57(4):443-57. PubMed ID: 16195878
[TBL] [Abstract][Full Text] [Related]
20. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
